HF
CMPX icon

HRT Financial’s Compass Therapeutics CMPX Stock Holding History

HRT Financial’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372K Buy
170,102
+150,251
+757% +$444K ﹤0.01% 2918
2026
Q1 		$105K Buy
+19,851
New +$115K ﹤0.01% 3347
2025
Q3 		– Sell
-60,778
Closed -$158K – 2951
2025
Q2 		$158K Buy
+60,778
New +$125K ﹤0.01% 2124
2024
Q3 		– Sell
-122,038
Closed -$122K – 2517
2024
Q2 		$122K Buy
+122,038
New +$178K ﹤0.01% 1737

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HRT Financial's CMPX Position: Q2 2026 in Review

HRT Financial increased its Compass Therapeutics (CMPX) stake by 757% in Q2 2026, buying an estimated $444K and bringing the position to 170,102 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #2918.

HRT Financial first reported a position in CMPX in Q2 2024 and has held it in 4 quarters since. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • HRT Financial held 170,102 shares of Compass Therapeutics worth $372K as of Q2 2026.
  • HRT Financial bought 150,251 Compass Therapeutics shares in Q2 2026, an estimated $444K.
  • Compass Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2918 holding.
  • HRT Financial first reported a position in Compass Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.